We are testing a new beta website for gov.scot go to new site

SSAC biographies

Scottish Science Advisory Committee Members

Anne GloverProfessor Anne Glover, FRSE, FAAM

Professor Anne Glover was appointed Chief Scientific Adviser for Scotland on August 1 2006. Her role is to further enhance Scotland's reputation as a science nation.

Professor Glover holds a Personal Chair of Molecular and Cell Biology at the University of Aberdeen, and has honorary positions at the Rowett and Macaulay Institutes. Professor Glover holds a Personal Chair of Molecular and Cell Biology at the University of Aberdeen, She is an elected Fellow of the Royal Society of Edinburgh, a member of the Natural Environment Research Council, and a Fellow of the American Academy of Microbiology.

Most of her academic career has been spent at the University of Aberdeen where she has an active research group pursuing a variety of areas from microbial diversity to the development and application of whole cell biosensors (biological sensors) for environmental monitoring and investigating how organisms respond to stress at a cellular level.

Steve BeaumontProfessor Steven P Beaumont, OBE, CEng, FREng, FRSE

Professor Steve Beaumont OBE CEng FREng FRSE took up the post of Vice-Principal for Research & Enterprise at the University of Glasgow on 1 January 2005. Professor Beaumont is responsible for the University's research strategy, policies and operational matters including negotiations and relationships with research sponsors and strategic partners. He also has responsibility for the University's enterprise activities, including research links with industry and the promotion of spinout companies.

Professor Beaumont's research background is in nanotechnology and nanoelectronics for which he was awarded the Order of the British Empire (OBE) in 2002. Before taking up his present position he was previously Head of Department of Electronics & Electrical Engineering and most recently Director of the Institute for System Level Integration. Professor Beaumont is Director of a number of University companies. He advises the Techmedia Intermediate Technology Institute as a member of its International Advisory Board, and was elected a Fellow of the Royal Society of Edinburgh (FRSE) in 2000, and more recently (July 2007) he was elected as a Fellow of the Royal Academy of Engineering (FREng).

Alan undy Professor Alan Bundy, FRSE, FAAAI, FAISB, FECCAI

Alan Bundy is Professor of Automated Reasoning in the School of Informatics at the University of Edinburgh. He is a fellow of several academic societies, including the Royal Society of Edinburgh, and the major awards for his research, include the IJCAI Research Excellence Award (2007) and the CADE Herbrand Award (2007). He was Head of Informatics at Edinburgh (1998-2001) and a member of: the Hewlett-Packard Research Board (1989-91); the ITEC Foresight Panel (1994-96), both the 2001 and 2008 Computer science RAE panels (1999-2001, 2005-2008). He was the founding Convener of the UKCRC (2000-2005). He is the author of 200 publications.

Professor Ian Underwood

Professor Ian Underwood FREng FRSE FInstP

Ian Underwood is a co-founder of MicroEmissive Displays (MED) and co-inventor of its P-OLED microdisplay technology. He was at The University of Edinburgh where he carried out pioneering research and development in the field of liquid crystal microdisplays between 1983 and 1999. His early career achievements were recognized by the following distinctions - a Fulbright Fellowship (1991) held at The University of Colorado, Photonics Spectra Circle of Excellence designer (1994), British Telecom Fellow (1997), Ben Sturgeon Award winner (1999).

In the late 1990's he contributed to the formation of Micropix Technologies (now Forth Dimension Displays). He designed the 1T-architecture XGA chip on which MicroPix's first product offerings were based and was consultant designer of the SXGA chip on which their subsequent product line is based. Since co-founding MED further honors include - Ernst & Young Emerging Entrepreneur of the Year, Scotland (2003), Fellow of the Royal Society of Edinburgh (2004), Gannochy Medal for Innovation winner (2004), Fellow of the Royal Academy of Engineering (2008) and Fellow of the Institute of Physics (2008). As co-founder of MED he shared responsibility for growing the company in its first four years from the point of foundation through three rounds of VC funding and to prototype development untilapproaching IPO-readiness Thereafter for several years, as Director of Strategic Marketing he was responsible for putting in place projects and programs to ensure that MED's future products will continue to meet the challenge of fast moving markets and innovative customers. MED's distinctions include a Guinness World Record (world's smallest colour tv screen, 2004), European Semiconductor Start-up Award (2004) and the inaugural IEE Innovation in Engineering Award for Emerging Technology (2005). As Chief Technology Officer through 2007 he ran MED's technology and product development programs.

He is recognized worldwide as an authority on microdisplay technology, systems and applications. In 2005, Ian was named Professor of Electronic Displays at The University of Edinburgh where he is currently Head of the Institute for Micro and Nano Systems (IMNS). In late 2007 he took up the Chair, also remaining part-time at MED as Chief Scientific Adviser. Until recently he sat on the Council of the Scottish Optoelectronics Association and the Steering Committee of ADRIA (Europe's Network in Advanced Displays). He is co-author of a recently released book entitled Introduction to Microdisplays (Wiley, 2006). In late 2008 he was appointed to the Scottish Science Advisory Council.

Michael FergusonProfessor Michael A.J. Ferguson CBE, FRS, FRSE, FMedSci

Mike Ferguson is Dean of Research for The College of Life Sciences, University of Dundee. His own research takes a multidisciplinary approach to understanding the biochemistry of protozoan parasites that cause tropical diseases. He believes in the fundamental importance of working across the Biology/Chemistry interface and in interdisciplinary research in general. He is particularly interested in Translational Research and, together with his colleagues, established the new Drug Discovery Unit at the University of Dundee. He is also Director of the Dundee Proteomics Facility and is involved with the Wyeth/Scottish Enterprise Translational Medicine Research Collaboration (TMRC).

Julie FitzpatrickProfessor Julie Fitzpatrick BVMS (Hons) MSc. PhD DipECBHM DipLSHTM CBiol FIBiol ARAgS MRCVS FRSE

Julie Fitzpatrick is the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Group. Professor Fitzpatrick's research interests focus on livestock health and disease in the UK and in developing countries, especially mastitis, and animal welfare.

Professor Fitzpatrick is a member of the University of Glasgow's Pain and Welfare Group, and she has an interest in developing means of assessing inflammation and immunity in endemic diseases of cattle and sheep. Professor Fitzpatrick is a member of the Royal College of Veterinary Surgeons (RCVS) Research Committee and she also sits on the Board of GALVmed, a public private partnership focusing on supporting the development of biologicals and therapeutics for orphan diseases in developing countries.

In Scotland, she sits on the recently formed Agriculture Strategy Implementation Group, the Animal Health and Welfare Advisory Group, and the recently appointed Agricultural Appeals Review Group for Scotland. She acted as Chairman of the BVA's Veterinary Policy Group (VPG) until 2007, and has been appointed to the RAE 2008 panel to assess veterinary, agricultural and food science areas. In 2003 she was awarded the G Norman Hall Medal for research into animal diseases by the RCVS Trust.

Dr Karen Jervis

Dr Jervis is Director of Business Development at CXR Biosciences, which follows a decade at the biotechnology company Viragen, where she was Managing Director and Head of Business Development. Dr Jervis holds a PhD in Protein Biochemistry from the University of Glasgow and an MBA (Master of Business Administration) from the University of Edinburgh. Dr Jervis has considerable experience in commercialisation of early stage technology and intellectual property strategy and management, holding several consulting positions, including at NextGen Bioscience Inc. and the Royal Zoological Society of Scotland and is a visiting lecturer in biotechnology at the University of Nottingham.

Prof Jim McDonald

Professor Jim McDonald, CEng, FIEE, FInstP, SMIEEE, FREng

Professor Jim McDonald spent 7 years within the UK Electricity Supply Industry. He joined Strathclyde University in 1984 ultimately being appointed as Rolls-Royce Professor of Electrical Power Systems in 1993. He advises government, industry and commerce on power networks, distributed generation and new/renewable energy. He has co-authored over 500 journal/conference papers and 3 books.

He is Director of the Institute for Energy and Environment the largest power engineering and energy systems research group internationally. He was appointed Deputy Principal at Strathclyde in 2006. In October 2006 he was appointed as Director of the Glasgow Research Partnership in Engineering (GRPE), part of a major research pooling investment across Scotland by SFC and HEIs.

Stuart MonroDr Stuart Monro, OBE, BSc, PhD, CGeol, FGS, FHEA, FRSSA

Stuart Monro is Scientific Director at Our Dynamic Earth and a leading practitioner in promoting science to a wide audience. He has over 34 years of scientific research experience with the British Geological Survey as a Principal Geologist. Stuart Monro has served a Non-Executive Director of the Edinburgh International Science Festival and on the Royal Society of Edinburgh's Young People's Committee.

He has significant experience of teaching geology at all levels in the Open University and has been a member of the Council of the Open University. He is also co-convener of the Scottish Earth Science Education Forum and Chair of the Earth Science Trust. In 2005 he was appointed as a Trustee of the National Museums of Scotland and was made an Honorary Fellow of the University of Edinburgh (School of Geosciences). From September 2007, he also serves as a member of the University Court of the University of Edinburgh.

Peter MorganProfessor Peter Morgan FRSE

Professor Peter Morgan is the Scientific Director and Chief Executive of the Rowett Research Institute (RRI), Aberdeen, and a Director on the Board of Rowett Research Services. As well as the Scottish Scientific Advisory Committee he sits on a number of steering groups for the Scottish Government's Chief Scientist's Office.

He is a member of the BBSRC DRINC Steering Committee, is a member of the Scientific Advisory Committee for the DIfE (Human Nutrition Institute) in Potsdam, Germany, and is a member of the Executive Committee of the NuGO Foundation as well as the Governing Council for the EU Framework VI Nutrigenomics Centre of Excellence programme. His personal research interests are in molecular endocrinology relating to biological rhythms and energy homeostasis.

Andy porter

Professor Andy J.R. Porter, FRSE

Andy Porter is Professor of Biotechnology and Deputy Director of the Institute of Medical Sciences, University of Aberdeen. Until recently he was also founder and CSO of Haptogen Ltd. Haptogen was acquired, in October 2007, by the US pharmaceutical giant Wyeth Inc.

In 2005 Andy was made Ernst and Young Plc, Science and Technology Entrepreneur of the Year. He has been a Fellow of the Royal Society of Edinburgh since 2006.

Since the sale of Haptogen, Andy has joined the Executive Committee of BIA Scotland, has accepted non-executive Board positions within the Scottish biotechnology sector, and has established a small venture fund investing in Scottish biotechnology companies.

Stuart W.J. Reid Stuart W.J. Reid BVMS PhD DVM DipECVPH FRSE MRCVS

Graduating from the University of Glasgow as a veterinary surgeon in 1987, Reid is Professor of Veterinary Epidemiology and Informatics holding the unique, joint chair between the Universities of Glasgow and Strathclyde since 1997.

His research focus is on quantitative epidemiology applied to human and animal health issues, at all levels of resolution, and has over 100 publications and over £15M in competitive grants to his name. Previously Associate Dean (Research) and now Dean of the Faculty of Veterinary Medicine at Glasgow, Reid leads one of the world's premier veterinary schools with a commitment to research, education and clinical care.

A vet with experience of the private and public sector, Reid has worked in Africa, the USA, is a Visiting Professor at the University of Sydney, is senior vice president of the European College of Veterinary Public Health and a member of the UK Veterinary Products Committee. He currently serves on the Scottish Science Advisory Committee and, until recently, was a member of the international scientific steering group of the Danish EpiLab. He is a Fellow of the Royal Society of Edinburgh, Scotland's National Academy, and sat on the Society's inquiries into Foot and Mouth Disease and Infectious Salmon Anaemia.

Ian Ritchie

Ian C Ritchie CBE, FREng, FRSE, FBCS

Ian Ritchie is the non-executive Chairman of Iomart plc, Scapa, CAS, Caspian Learning and the Interactive Design Institute. He has been involved in over 20 start-up high-tech businesses, including OWL, Digital Bridges, Voxar, Sonaptic and Orbital.

Ritchie is a past-President of the British Computer Society. He is a Fellow of the Royal Academy of Engineering (FREng) and the Royal Society of Edinburgh (FRSE). He serves on the boards of the National Museums of Scotland, the Edinburgh International Film Festival, Bletchley Park Trust, and Our Dynamic Earth. He was awarded a CBE in the 2003 New Years Honours list.

Barbara SpruceDr Barbara Spruce MB.BS, MRCP, PhD,

Dr Spruce is a Senior Lecturer in the Department of Surgery and Molecular Oncology, University of Dundee. Dr Spruce is a physician scientist whose interests and experience lie principally in the delivery of academic research to the clinical arena.

She has expertise in the alignment of translational research with a commercial strategy, the product of which has been a successful licensing deal with a drug development company, Modern Biosciences plc, to deliver a new cancer therapy to the clinic.

Dr Spruce has received funding for translational work from a number of sources including the Wellcome Trust and Scottish Enterprise. In 2003 she was awarded the inaugural Gannochy Trust Innovation Award of the Royal Society of Edinburgh for her work in the area of cancer drug discovery and development.

Joyce Tait

Professor Joyce Tait , CBE, FRSE, PhD

Joyce Tait is the former Director and now Scientific Advisor of the ESRC Innogen Centre (Centre for Social and Economic Research on Innovation in Genomics).

She is a Professor in the University of Edinburgh with an interdisciplinary background, covering natural and social sciences, particularly developments in life sciences, strategic and operational decision making in companies and public bodies; policy analysis; risk assessment and regulation; Foresight; and public attitudes and communication.

Current research foci include GM crops, stem cells, genetic databases, the agro-biotechnology and pharmaceutical industries and their governance, and synthetic genomics. She is a member of: the Board of Directors of the Scottish Stem Cell Network; the Scientific and Technical Council of the International Risk Governance Council and the Governing Council of the Roslin Institute.

Bob Tooze

Professor Robert Tooze, BSc, ARCS, PhD, DIC, CChem, MRSC.

Professor Tooze is Managing Director of Sasol Technology UK Ltd. He has worked in the chemical industry for over 20 years, mainly for ICI, working in various businesses and locations but always in R&D. He joined Sasol Technology UK (STUK) in 2002 as Research Director and was made Managing Director in 2004.

He has wide experience of collaborative research both nationally and internationally. He is also currently Chairman of the Industrial Board of IdeCat, an integrated network of 40 of the leading Catalysis Laboratories in Europe, funded by the EU as well as holding an Honorary Professorship in Chemistry at the University of St Andrews where STUK is based.

Chris van der kuylProfessor Chris van der Kuyl, BSc(Hons), FRSE

Chris van der Kuyl is CEO of Scotland Online an internet service provider and Chairman of the Tayforth Group which has diverse interests in Video Game development and Intellectual Property development across all entertainment sectors. He is acknowledged widely as among the leading entrepreneurs in his native Scotland and has won various awards.

Between 2000-2002 Chris was a member of the Global Leaders of Tomorrow Programme at the World Economic Forum. Outside his business interests Chris spends time encouraging enterprise education in schools, colleges and universities. He was Chairman of Young Enterprise Scotland for seven years, is a member of the Entrepreneurial Exchange and sits on the influential Smith Group advising the Scottish Executive on educational matters.

Graham WrenEurIng Graham Wren, FIMechE, FRSA, CEng, CDir, CMar.

Graham Wren is Managing Director, GSE Systems Limited.

He has a background in engineering design and project management but now focuses on managing the interface between basic ideas and commercialisation.

He has been responsible for a number of start up companies and he has a key interest in the growth of scientific based companies in Scotland.

He is currently working on a number of start up companies and R&D projects in Scotland.

Roland Wolf

Professor Roland Wolf, FRSE, FMedSci, FSA, FBTS

Professor Roland Wolf is Director, University of Dundee Biomedical Research Centre; Honorary Director, Cancer Research UK Molecular Pharmacology Unit; and Scientific Director, CXR Biosciences Ltd., Dundee, UK. Professor Roland Wolf has an international reputation in the field of molecular pharmacology, specifically cancer therapy. He has published over 400 journal papers and is a member of numerous national and international committees and advisory panels on toxicology and safety issues. In 2001, Professor Wolf founded CXR Biosciences a drug discovery company with a major focus on developing new models to accelerate drug development process. As consequence of longstanding collaboration with Wyeth, Professor Wolf was a key player in initiating the Translational Medicine Research Collaboration (TMRC) in Scotland.